Cargando…

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation

Risk stratification in heart failure (HF) patients is an important element for management. There are several risk stratification models that can be used to predict the prognosis of patients with HF, such as Aaronson's scale, CVM-HF (CardioVascular Medicine Heart Failure), the Seattle Heart Fail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szyguła-Jurkiewicz, Bożena, Zakliczyński, Michał, Andrejczuk, Mariusz, Mościński, Mateusz, Zembala, Marian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Heart and Lung Failure, Transplantology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283859/ https://www.ncbi.nlm.nih.gov/pubmed/26336418 http://dx.doi.org/10.5114/kitp.2014.43847

Ejemplares similares

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Monitoring hemostasis parameters in left ventricular assist device recipients – a preliminary report
por: Hudzik, Bartosz, et al.
Publicado: (2016)

Coincidence of cellular and antibody mediated rejection in heart transplant recipients – preliminary report
por: Zakliczyński, Michał, et al.
Publicado: (2014)

Bridge to recovery in two cases of dilated cardiomyopathy after long-term mechanical circulatory support
por: Pacholewicz, Jerzy, et al.
Publicado: (2014)

Influence of proliferation signal inhibitors on vascular endothelial growth factor production in heart transplant recipients – preliminary report
por: Kamieńska, Natalia, et al.
Publicado: (2014)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

A functional assessment of patients two years after lung transplantation in Poland
por: Jastrzębski, Dariusz T., et al.
Publicado: (2014)

Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
por: Pyka, Łukasz, et al.
Publicado: (2017)

Meeting Update: International Society for Heart and Lung Transplantation 2014
por: Baran, David A., et al.
Publicado: (2015)

Is cytoimmunological monitoring a safe follow-up method for heart transplantation patients?
por: Cingoz, Faruk, et al.
Publicado: (2014)

Does the postoperative troponin I blood concentration measured in the perioperative period influence hemodynamic function of a transplanted heart?
por: Wierzbicki, Karol, et al.
Publicado: (2014)

The impact of chronic kidney disease on the annual prognosis in patients 80+ years old suffering from chronic heart failure
por: Cichocka-Radwan, Anna, et al.
Publicado: (2014)

Surgery for massive malignant tumors of the left atrium – one center’s experience
por: Andrushchuk, Uladzimir, et al.
Publicado: (2016)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
por: Ciszek, Michał
Publicado: (2013)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018)

Prevalence of P wave dispersion and interatrial block in patients with systolic heart failure and their relationship with functional status, hospitalization and one year mortality
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Protonotarios, Alexandros, et al.
Publicado: (2020)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Asymptomatic Left Ventricle Systolic Dysfunction
por: Sara, Jaskanwal D, et al.
Publicado: (2020)

Contemporary Management of Secondary Mitral Regurgitation
por: Goel, Kashish, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dk3fun5lg9qdfd4mg0vb1mf1ka